Oxford, United Kingdom

Christopher Norman Lewis


Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Cowley St. John, GB (1993)
  • Oxford, GB (1994 - 2001)
  • Cowley, GB (2000 - 2001)

Company Filing History:


Years Active: 1993-2001

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Christopher Norman Lewis: Innovator in Metalloproteinase Inhibitors

Introduction

Christopher Norman Lewis is a distinguished inventor based in Oxford, GB. He holds a total of 8 patents, showcasing his significant contributions to the field of biotechnology. His work primarily focuses on the development of innovative compounds and processes that have the potential to impact various medical applications.

Latest Patents

Among his latest patents, Lewis has developed metalloproteinase inhibitors, which are crucial in the treatment of various diseases. One notable invention is a compound of formula (I) that demonstrates promising therapeutic properties. Additionally, he has synthesized hydroxamic acid derivatives, detailing processes for preparing synthetic products that include a covalently bonded hydroxamic acid group. This invention involves forming a mixture of a liquid reaction medium and a solid phase reaction product that carries multiple moieties of specific formulas.

Career Highlights

Throughout his career, Christopher Norman Lewis has worked with reputable companies such as British Biotech Pharmaceuticals Limited and British Bio-technology Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in biotechnology.

Collaborations

Lewis has collaborated with notable coworkers, including Fionna Mitchell Martin and Christopher David Floyd. Their combined expertise has fostered an environment of innovation and creativity in their respective projects.

Conclusion

Christopher Norman Lewis is a prominent figure in the field of biotechnology, with a strong portfolio of patents that reflect his innovative spirit. His work on metalloproteinase inhibitors and hydroxamic acid derivatives highlights his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…